Thomas Civik insider trades

Open-market stock purchases and sales by Thomas Civik, CEO & Chairman of the Board at Pyxis Oncology, Inc, from SEC Form 4 filings since Jan 1, 2018.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -89%.

Recent trades

DateStockTradeValue
Sep 4, 2026PYXS Pyxis Oncology, IncBought (not open market)—
Aug 12, 2026PYXS Pyxis Oncology, IncBought (not open market)—
Feb 3, 2026PYXS Pyxis Oncology, IncBought (not open market)—
Jan 28, 2026RPTX Repare Therapeutics IncSold (not open market)—

Companies traded

  • PYXS Pyxis Oncology, Inc: 1 buy, last Sep 4, 2026
  • RPTX Repare Therapeutics Inc: 1 buy, last Jan 28, 2026
  • FPRX Five Prime Therapeutics, Inc: other filings, last Apr 16, 2021
  • FMI Foundation Medicine, Inc: other filings, last Jul 31, 2018

Get free alerts when Thomas Civik files a new trade →